Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Department of Medical Oncology, Thomas Jefferson University School of Medicine, Philadelphia, Pennsylvania.
Transplant Cell Ther. 2023 Sep;29(9):539-547. doi: 10.1016/j.jtct.2023.06.014. Epub 2023 Jun 26.
The use of electronic health/medical record (EMR) systems has streamlined medical practice and improved efficiency of clinical care in recent years. However, EMR systems are not generally well designed to support research and tracking of longitudinal outcomes across populations, which are particularly important in hematopoietic stem cell transplantation (HCT) and immune effector cell therapy (IEC), where data reporting to registries and regulatory agencies are often required. Since its formation in 2014, the HCT EMR user group has worked with a large EMR vendor (Epic) to develop many functionalities within the EMR to improve the care of HCT/IEC patients and facilitate the capture of HCT/IEC data in an easily interoperable format. Awareness and the widespread adoption of these new tools among transplant centers remains a challenge, however. In this report, we aim to increase awareness and adoption of these new features in the Epic EMR across the transplantation community, advocate for the use of data standards, and promote future collaboration with other commercial EMRs to develop standardized HCT/IEC content to improve patient care and facilitate interoperable data exchange.
近年来,电子健康/医疗记录 (EMR) 系统的使用简化了医疗实践并提高了临床护理的效率。然而,EMR 系统通常设计不佳,无法支持对人群进行纵向结果的研究和跟踪,这在造血干细胞移植 (HCT) 和免疫效应细胞治疗 (IEC) 中尤为重要,因为这些治疗需要向登记处和监管机构报告数据。自 2014 年成立以来,HCT EMR 用户组一直与一家大型 EMR 供应商(Epic)合作,在 EMR 中开发了许多功能,以改善 HCT/IEC 患者的护理,并以易于互操作的格式方便地捕获 HCT/IEC 数据。然而,移植中心对这些新工具的认识和广泛采用仍然是一个挑战。在本报告中,我们旨在提高移植界对 Epic EMR 中这些新功能的认识和采用,倡导使用数据标准,并促进与其他商业 EMR 的未来合作,以开发标准化的 HCT/IEC 内容,改善患者护理并促进互操作数据交换。